Physician profile

David W Epstein

General Practice (Dentist) · Novato, CA

NPI 1033127923

$2,220.58

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$683.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimvie INC. $684.11 2022-2023
Straumann USA LLC $633.84 2020-2024
Biohorizons Implant Systems INC. $428.51 2019-2022
S.I.N. Implant System Ltda. $199.22 2023
Zimmer Biomet Holdings, INC. $75.00 2020
Salvin Dental Specialties, INC. $54.76 2021
Dentsply Sirona INC $51.78 2023-2024 Consumable Dentistry, Symbios
Keystone Dental INC. $47.06 2019
Geistlich Pharma, North America, INC. $46.30 2024 Geistlich Bio-Gide

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David W Epstein

$2,220.58

in general payments reported 2019-2025

Years
2019-2024
Top company
Zimvie INC.

https://glasscript.com/doctor/1047549/david-w-epstein

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.